T Cell Responses to HIV Drug Resistance Mutation
Author Information
Author(s): Mahnke Lisa, Clifford David
Primary Institution: Washington University School of Medicine
Hypothesis
In certain individuals, CTL responses against 103N-containing epitopes may protect against NNRTI drug resistance.
Conclusion
The study found that T cells in some HIV-1 infected patients can recognize a peptide containing the K103N mutation, which is associated with drug resistance.
Supporting Evidence
- T cell activity was observed against the K103N region in three HIV-1 infected patients.
- A nine amino acid peptide incorporating K103N was recognized by patient T cells.
- The study suggests that CTL responses may help prevent drug resistance in HIV.
Takeaway
Some people's immune systems can fight against a specific HIV mutation that makes the virus resistant to certain drugs.
Methodology
The study involved recruiting HIV-1 infected patients, collecting blood samples, and analyzing T cell responses using ELISPOT assays.
Limitations
The study had a small sample size and focused on specific patient demographics.
Participant Demographics
10 patients, 6 men and 4 women, aged 30-60 years, chronically infected with HIV-1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website